Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY.
Yuen KC, Tritos NA, Samson SL, Hoffman AR, Katznelson L. Yuen KC, et al. Among authors: katznelson l. Endocr Pract. 2016 Oct;22(10):1235-1244. doi: 10.4158/EP161407.DSCR. Epub 2016 Jul 13. Endocr Pract. 2016. PMID: 27409821 Review.
However, several recent studies have questioned the diagnostic accuracy of the GST when the GH cut-point of 3 μg/L is used and have suggested that a lower GH cut-point of 1 μg/L improved the sensitivity and specificity of this test in overweight/obese patients and i …
However, several recent studies have questioned the diagnostic accuracy of the GST when the GH cut-point of 3 μg/L is used and have s …
Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.
Baum HB, Biller BM, Katznelson L, Oppenheim DS, Clemmons DR, Cannistraro KB, Schoenfeld DA, Best SA, Klibanski A. Baum HB, et al. Among authors: katznelson l. J Clin Endocrinol Metab. 1996 Jan;81(1):84-92. doi: 10.1210/jcem.81.1.8550799. J Clin Endocrinol Metab. 1996. PMID: 8550799

The mean overnight GH level in patients was 0.6 +/- 0.0 microgram/L compared to 1.0 +/- 0.1 microgram/L in controls (P < 0.0001). The mean 24-h GH level in patients was 0.5 +/- 0.0 microgram/L compared to 0.8 +/- 0.1 microgram/L in normal controls (

The mean overnight GH level in patients was 0.6 +/- 0.0 microgram/L compared to 1.0 +/- 0.1 microgram/L in controls (P < 0.

Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency.
Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, Cannistraro KE, Klibanski A. Baum HB, et al. Among authors: katznelson l. J Clin Endocrinol Metab. 1998 Sep;83(9):3184-9. doi: 10.1210/jcem.83.9.5112. J Clin Endocrinol Metab. 1998. PMID: 9745423 Clinical Trial.
AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly.
Cook DM, Ezzat S, Katznelson L, Kleinberg DL, Laws ER Jr, Nippoldt TB, Swearingen B, Vance ML; AACE Acromegaly Guidelines Task Force. Cook DM, et al. Among authors: katznelson l. Endocr Pract. 2004 May-Jun;10(3):213-25. doi: 10.4158/EP.10.3.213. Endocr Pract. 2004. PMID: 15382339 No abstract available.
Approach to the evaluation of the GH/IGF-axis in patients with pituitary disease: which test to order.
Roberts B, Katznelson L. Roberts B, et al. Among authors: katznelson l. Pituitary. 2007;10(2):205-11. doi: 10.1007/s11102-007-0026-x. Pituitary. 2007. PMID: 17429594
Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone.
Weiss DE, Vogel H, Lopes MB, Chang SD, Katznelson L. Weiss DE, et al. Among authors: katznelson l. Endocr Pract. 2011 Jan-Feb;17(1):79-84. doi: 10.4158/EP10165.CR. Endocr Pract. 2011. PMID: 20713338
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.
Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK; American Association of Clinical Endocrinologists. Katznelson L, et al. Endocr Pract. 2011 Jul-Aug;17 Suppl 4:1-44. doi: 10.4158/ep.17.s4.1. Endocr Pract. 2011. PMID: 21846616 No abstract available.
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly--2011 update: executive summary.
Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK; AACE Acromegaly Task Force. Katznelson L, et al. Endocr Pract. 2011 Jul-Aug;17(4):636-46. doi: 10.4158/ep.17.4.636. Endocr Pract. 2011. PMID: 21846619 No abstract available.
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.
Yuen KC, Biller BM, Katznelson L, Rhoads SA, Gurel MH, Chu O, Corazzini V, Spiller K, Gordon MB, Salvatori R, Cook DM. Yuen KC, et al. Among authors: katznelson l. Pituitary. 2013 Jun;16(2):220-30. doi: 10.1007/s11102-012-0407-7. Pituitary. 2013. PMID: 22806554
Clinical characteristics and pituitary dysfunction in patients with metastatic cancer to the sella.
Ariel D, Sung H, Coghlan N, Dodd R, Gibbs IC, Katznelson L. Ariel D, et al. Among authors: katznelson l. Endocr Pract. 2013 Nov-Dec;19(6):914-9. doi: 10.4158/EP12407.OR. Endocr Pract. 2013. PMID: 23757610
130 results
Jump to page
Feedback